145 related articles for article (PubMed ID: 9386863)
1. Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients.
Bascioni R; Giorgi F; Silva RR; Acito L; Giustini L; De Signoribus G; Giuliodori L; Testa E
Breast Cancer Res Treat; 1997 Sep; 45(3):205-10. PubMed ID: 9386863
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
Repetto L; Miglietta L; Gardin G; Lanfranco C; Naso C; Merlini L; Giudici S; Venturino A; Campora E; Testore F
Breast Cancer Res Treat; 1994; 30(2):133-7. PubMed ID: 7949211
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
5. Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin.
Colozza M; Gori S; Mosconi AM; Anastasi P; Basurto C; Ludovini V; De Angelis V; Giansanti M; Tonato M
Breast Cancer Res Treat; 1996; 38(3):277-82. PubMed ID: 8739080
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: a phase II study.
Susnjar S; Vasović S; Nesković-Konstantinović Z; Stamatović L; Lukić V; Colaković S; Mitrovic L; Jelić S; Radulović S
Tumori; 1999; 85(6):478-82. PubMed ID: 10774569
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.
Lorusso V; Mancarella S; Catino A; Brandi M; Paradiso A; Latorre A; Mastria A; De Mitrio A; Guida M; De Lena M
Tumori; 1999; 85(1):60-4. PubMed ID: 10228500
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
Gebbia V; Borsellino N; Testa A; Tirrito M; Varvara F; Cucchiara A; Mauceri G; Girlando A; Ferrara M; Caruso F
Anticancer Res; 1999; 19(4C):3553-7. PubMed ID: 10629652
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH
Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
Hainsworth JD; Jones SE; Mennel RG; Blum JL; Greco FA
J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial.
Deprés-Brummer P; Berthault-Cvitkovic F; Lĕvi F; Brienza S; Vannetzel JM; Jasmin C; Misset JL
J Infus Chemother; 1995; 5(3 Suppl 1):144-7. PubMed ID: 8528975
[TBL] [Abstract][Full Text] [Related]
13. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study.
Oliva C; Bergnolo P; Inguì M; Bianco L; Pochettino P; Cutin SC; Boglione A; Dal Canton O; Garetto F; Comandone A
J Cancer Res Clin Oncol; 2010 Mar; 136(3):411-7. PubMed ID: 19727815
[TBL] [Abstract][Full Text] [Related]
15. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
[TBL] [Abstract][Full Text] [Related]
16. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients.
Mammoliti S; Merlini L; Caroti C; Gallo L
Breast Cancer Res Treat; 1996; 37(1):93-6. PubMed ID: 8750532
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
Klaassen U; Harstrick A; Wilke H; Seeber S
Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
[TBL] [Abstract][Full Text] [Related]
19. Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer.
Louvet C; de Gramont A; Demuynck B; Beerblock K; Varette C; Soubrane D; Marpeau L; Pigné A; Guillot T; Krulik M
Eur J Cancer; 1993; 29A(13):1835-8. PubMed ID: 8260236
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
